112 related articles for article (PubMed ID: 6802116)
21. Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins.
Schmitz G; Assmann G; Rall SC; Mahley RW
Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6081-5. PubMed ID: 6412234
[TBL] [Abstract][Full Text] [Related]
22. The covalent structure of apolipoprotein A-I from canine high density lipoproteins.
Chung H; Randolph A; Reardon I; Heinrikson RL
J Biol Chem; 1982 Mar; 257(6):2961-7. PubMed ID: 6801039
[TBL] [Abstract][Full Text] [Related]
23. Interaction between high-density lipoprotein subpopulations in apo B-free and abetalipoproteinemic plasma.
Cheung MC; Wolf AC; Illingworth DR
Biochim Biophys Acta; 1992 Oct; 1128(2-3):244-9. PubMed ID: 1420297
[TBL] [Abstract][Full Text] [Related]
24. Lipid and apoprotein modifications in body builders during and after self-administration of anabolic steroids.
Baldo-Enzi G; Giada F; Zuliani G; Baroni L; Vitale E; Enzi G; Magnanini P; Fellin R
Metabolism; 1990 Feb; 39(2):203-8. PubMed ID: 2105436
[TBL] [Abstract][Full Text] [Related]
25. Preliminary report: kinetic studies on the modulation of high-density lipoprotein, apolipoprotein, and subfraction metabolism by sex steroids in a postmenopausal woman.
Hazzard WR; Haffner SM; Kushwaha RS; Applebaum-Bowden D; Foster DM
Metabolism; 1984 Sep; 33(9):779-84. PubMed ID: 6433146
[TBL] [Abstract][Full Text] [Related]
26. Relationships of serum lipoproteins and apoproteins to sex hormones and to the binding capacity of sex hormone binding globulin in healthy Finnish men.
Hämäläinen E; Adlercreutz H; Ehnholm C; Puska P
Metabolism; 1986 Jun; 35(6):535-41. PubMed ID: 3086660
[TBL] [Abstract][Full Text] [Related]
27. Serum lipids and apolipoproteins A-I, A-II and B in primary hypothyroidism before and during treatment.
Muls E; Rosseneu M; Blaton V; Lesaffre E; Lamberigts G; de Moor P
Eur J Clin Invest; 1984 Feb; 14(1):12-5. PubMed ID: 6421595
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies to human plasma low-density lipoproteins. II. Evaluation for use in radioimmunoassay for apolipoprotein B in patients with coronary artery disease.
Patton JG; Badimon JJ; Mao SJ
Clin Chem; 1983 Nov; 29(11):1898-903. PubMed ID: 6627628
[TBL] [Abstract][Full Text] [Related]
29. Displacement of apo A-I by A-II in lipid-apoprotein complexes and human HDL.
Rosseneu M; Van Tornout P; Caster H; Lievens MJ
Acta Cardiol Suppl; 1981; 27():11-29. PubMed ID: 6801887
[TBL] [Abstract][Full Text] [Related]
30. Immunochemistry of human plasma apolipoprotein C-II as studied by radioimmunoassay.
Barr SI; Kottke BA; Chang JY; Mao SJ
Biochim Biophys Acta; 1981 Feb; 663(2):491-505. PubMed ID: 7213782
[TBL] [Abstract][Full Text] [Related]
31. Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics.
Briones ER; Mao SJ; Palumbo PJ; O'Fallon WM; Chenoweth W; Kottke BA
Metabolism; 1984 Jan; 33(1):42-9. PubMed ID: 6419012
[TBL] [Abstract][Full Text] [Related]
32. Interaction of apolipoprotein A-II with recombinant HDL containing egg phosphatidylcholine, unesterified cholesterol and apolipoprotein A-I.
Rye KA
Biochim Biophys Acta; 1990 Feb; 1042(2):227-36. PubMed ID: 2105749
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein and lipid composition of plasma lipoproteins in neonates during the first month of life.
van Biervliet JP; Rosseneu M; Bury J; Caster H; Stul MS; Lamote R
Pediatr Res; 1986 Apr; 20(4):324-8. PubMed ID: 3085061
[TBL] [Abstract][Full Text] [Related]
34. Metabolic effects of a biphasic oral contraceptive preparation containing ethinyloestradiol and desogestrel on serum lipoproteins and apolipoproteins.
Voorhoof L; Rosseneu M; Caster H; De Keersgieter W
J Endocrinol; 1986 Oct; 111(1):191-6. PubMed ID: 2946795
[TBL] [Abstract][Full Text] [Related]
35. Determination of human apolipoprotein C-II by electroimmunoassay. Studies on standardization and determination before and after physical training.
Jauhiainen M; Laitinen M; Penttilä I; Puhakainen E; Hietanen E
Int J Biochem; 1983; 15(4):501-6. PubMed ID: 6406281
[TBL] [Abstract][Full Text] [Related]
36. Serum apolipoprotein A-I levels: relationship to lipoprotein lipid levels and selected demographic variables.
Phillips NR; Havel RJ; Kane JP
Am J Epidemiol; 1982 Aug; 116(2):302-13. PubMed ID: 6810694
[TBL] [Abstract][Full Text] [Related]
37. Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.
Cheung MC; Mendez AJ; Wolf AC; Knopp RH
J Clin Invest; 1993 Feb; 91(2):522-9. PubMed ID: 8432861
[TBL] [Abstract][Full Text] [Related]
38. Tween-20 increases the immunoreactivity of apolipoprotein A-I in plasma.
Mao SJ; Kottke BA
Biochim Biophys Acta; 1980 Dec; 620(3):447-53. PubMed ID: 7236651
[TBL] [Abstract][Full Text] [Related]
39. Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency.
Havel RJ; Kotite L; Vigne JL; Kane JP; Tun P; Phillips N; Chen GC
J Clin Invest; 1980 Dec; 66(6):1351-62. PubMed ID: 7440719
[TBL] [Abstract][Full Text] [Related]
40. Age- and sex-related differences in lipoproteins containing apoprotein A-I.
Ohta T; Hattori S; Murakami M; Nishiyama S; Matsuda I
Arteriosclerosis; 1989; 9(1):90-5. PubMed ID: 2492188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]